Hill CH - Search Results

1

Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction.

Bit RA, Davis PD, Elliott LH, Harris W, Hill CH, Keech E, Kumar H, Lawton G, Maw A, Nixon JS, et al. Bit RA, et al. Among authors: hill ch. J Med Chem. 1993 Jan 8;36(1):21-9. doi: 10.1021/jm00053a003. J Med Chem. 1993. PMID: 8421286

2

The design and biological properties of potent and selective inhibitors of protein kinase C.

Nixon JS, Bishop J, Bradshaw D, Davis PD, Hill CH, Elliott LH, Kumar H, Lawton G, Lewis EJ, Mulqueen M, et al. Nixon JS, et al. Among authors: hill ch. Biochem Soc Trans. 1992 May;20(2):419-25. doi: 10.1042/bst0200419. Biochem Soc Trans. 1992. PMID: 1397642 Review. No abstract available.

3

Oral, anti-inflammatory activity of a potent, selective, protein kinase C inhibitor.

Mulqueen MJ, Bradshaw D, Davis PD, Elliott L, Griffiths TA, Hill CH, Kumar H, Lawton G, Nixon JS, Sedgwick AD, et al. Mulqueen MJ, et al. Among authors: hill ch. Agents Actions. 1992 Sep;37(1-2):85-9. doi: 10.1007/BF01987894. Agents Actions. 1992. PMID: 1456183

4

Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity.

Davis PD, Elliott LH, Harris W, Hill CH, Hurst SA, Keech E, Kumar MK, Lawton G, Nixon JS, Wilkinson SE. Davis PD, et al. Among authors: hill ch. J Med Chem. 1992 Mar 20;35(6):994-1001. doi: 10.1021/jm00084a004. J Med Chem. 1992. PMID: 1552513

5

Inhibitors of protein kinase C. 1. 2,3-Bisarylmaleimides.

Davis PD, Hill CH, Lawton G, Nixon JS, Wilkinson SE, Hurst SA, Keech E, Turner SE. Davis PD, et al. Among authors: hill ch. J Med Chem. 1992 Jan;35(1):177-84. doi: 10.1021/jm00079a024. J Med Chem. 1992. PMID: 1732526

6

Novel, potent and selective inhibitors of protein kinase C show oral anti-inflammatory activity.

Nixon JS, Bishop J, Bradshaw D, Davis PD, Hill CH, Elliott LH, Kumar H, Lawton G, Lewis EJ, Mulqueen M, et al. Nixon JS, et al. Among authors: hill ch. Drugs Exp Clin Res. 1991;17(8):389-93. Drugs Exp Clin Res. 1991. PMID: 1822831

7

K252a is a potent and selective inhibitor of phosphorylase kinase.

Elliott LH, Wilkinson SE, Sedgwick AD, Hill CH, Lawton G, Davis PD, Nixon JS. Elliott LH, et al. Among authors: hill ch. Biochem Biophys Res Commun. 1990 Aug 31;171(1):148-54. doi: 10.1016/0006-291x(90)91369-4. Biochem Biophys Res Commun. 1990. PMID: 2393389

8

Potent selective inhibitors of protein kinase C.

Davis PD, Hill CH, Keech E, Lawton G, Nixon JS, Sedgwick AD, Wadsworth J, Westmacott D, Wilkinson SE. Davis PD, et al. Among authors: hill ch. FEBS Lett. 1989 Dec 18;259(1):61-3. doi: 10.1016/0014-5793(89)81494-2. FEBS Lett. 1989. PMID: 2532156 Free article.

9

Therapeutic potential of protein kinase C inhibitors.

Bradshaw D, Hill CH, Nixon JS, Wilkinson SE. Bradshaw D, et al. Among authors: hill ch. Agents Actions. 1993 Jan;38(1-2):135-47. doi: 10.1007/BF02027225. Agents Actions. 1993. PMID: 8480534 Review.

10

Structure-based design of peptidomimetic antagonists of p56(lck) SH2 domain.

Hobbs CJ, Bit RA, Cansfield AD, Harris B, Hill CH, Hilyard KL, Kilford IR, Kitas E, Kroehn A, Lovell P, Pole D, Rugman P, Sherborne BS, Smith IE, Vesey DR, Walmsley DL, Whittaker D, Williams G, Wilson F, Banner D, Surgenor A, Borkakoti N. Hobbs CJ, et al. Among authors: hill ch. Bioorg Med Chem Lett. 2002 May 20;12(10):1365-9. doi: 10.1016/s0960-894x(02)00167-1. Bioorg Med Chem Lett. 2002. PMID: 11992778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page